ARISTO PHARMA refers to a group of affiliated, but distinct, pharmaceutical companies operating in different regions (primarily Europe and India/Bangladesh). They generally share a philosophy of producing high-quality, cost-effective medicines.

Aristo Pharma (Europe/Germany)

The European Aristo Pharma Group is headquartered in Berlin, Germany, and was founded in 2008 through the merger of various traditional German pharmaceutical companies.

Focus:
The company primarily produces generic medicines (cost-effective versions of important original products) as well as over-the-counter (OTC) products and in-house developments.

Operations:
It has five production sites in Germany and Spain, and a logistics center, employing over 1,750 people within the group across various European markets.

Mission:
Its philosophy is to ensure that a wide range of high-quality, essential medicines remain affordable and accessible to the public, thus supporting healthcare systems.

Products:
Their portfolio covers a broad range of therapeutic areas, including dermatology, gynecology, urology, psychiatry, and neurology.

Aristo Pharmaceuticals (India/Bangladesh)

There are also prominent companies with the “Aristo” name in India and Bangladesh, which are separate entities but linked by their founder.

Aristopharma Ltd. (Bangladesh):
This company was established in 1986 and is one of the top 10 pharmaceutical companies in Bangladesh. It is a market leader in ophthalmic products and manufactures a wide range of dosage forms including inhalers, injections, and biotech products.

Aristo Pharmaceuticals Pvt. Ltd. (India):
Incorporated in 1971, this private limited company in Mumbai, India, is a significant player in the Indian market, known for its strong presence in antibiotic and cardio-diabetic therapy segments. It has a dedicated R&D department and cGMP-compliant manufacturing facilities.
Both groups emphasize quality, affordability, and extensive research and development in their operations.